{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:17:32Z","timestamp":1792052252432,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.berh.2026.102116","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:36:02Z","timestamp":1770150962000},"page":"102116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Juvenile systemic sclerosis"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0659-5298","authenticated-orcid":false,"given":"Ivan","family":"Foeldvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare E.","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2026.102116_bib1","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3899\/jrheum.100001","article-title":"Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort","volume":"37","author":"Foeldvari","year":"2010","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2026.102116_bib2","first-page":"1004","article-title":"Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease","volume":"33","author":"Scalapino","year":"2006","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102116_bib3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/rheumatology\/kes144","article-title":"Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database","volume":"51","author":"Foeldvari","year":"2012","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/23971983221143244","article-title":"Gender differences in juvenile systemic sclerosis patients: results from the international juvenile scleroderma inception cohort","volume":"8","author":"Foeldvari","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2397198318763701","article-title":"Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States","volume":"3","author":"Beukelman","year":"2018","journal-title":"J Scleroderma Related Dis"},{"key":"10.1016\/j.berh.2026.102116_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251370871","article-title":"Incidence and prevalence of juvenile SSc in the United States: an analysis by age group","author":"Mattson","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.berh.2026.102116_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2397198318763701","article-title":"The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States","volume":"3","author":"Beukelman","year":"2018","journal-title":"J Scleroderma Related Dis"},{"issue":"11","key":"10.1016\/j.berh.2026.102116_bib9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101688","article-title":"Review for best practice in clinical rheumatology juvenile systemic sclerosis - updates and practice points","volume":"35","author":"Foeldvari","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.22551","article-title":"The pediatric rheumatology European society\/American college of rheumatology\/European league against rheumatism provisional classification criteria for juvenile systemic sclerosis","volume":"57","author":"Zulian","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2026.102116_bib12","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma trial and research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102116_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/BOR.0000000000000113","article-title":"Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement","volume":"26","author":"Domsic","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102116_bib14","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102116_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/acr.24609","article-title":"Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in an expanded international cohort","volume":"74","author":"Foeldvari","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2026.102116_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152197","article-title":"Juvenile and adult-onset scleroderma: different clinical phenotypes","volume":"60","author":"Adrovic","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2026.102116_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/rheumatology\/39.5.556","article-title":"Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey","volume":"39","author":"Foeldvari","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102116_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","article-title":"Factors affecting survival in juvenile systemic sclerosis","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/1744666X.2023.2298354","article-title":"Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the international Hamburg consensus meeting December 2022","volume":"20","author":"Foeldvari","year":"2024","journal-title":"Expet Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/keaa584","article-title":"Consensus-based recommendations for the management of juvenile systemic sclerosis","volume":"60","author":"Foeldvari","year":"2021","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2026.102116_bib22","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1093\/rheumatology\/keaf249","article-title":"Evaluating the relevance of the 2024 BSR systemic sclerosis guideline for juvenile systemic sclerosis","volume":"64","author":"Pain","year":"2025","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2026.102116_bib24","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib26","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102116_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/BOR.0000000000000968","article-title":"Methods for objective assessment of skin involvement in systemic sclerosis","volume":"35","author":"Desai","year":"2023","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s42358-020-00152-6","article-title":"Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study","volume":"60","author":"de Oliveira","year":"2020","journal-title":"Adv Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ultrasmedbio.2023.12.017","article-title":"Evaluating skin involvement in systemic sclerosis using high-frequency ultrasound and virtual touch tissue imaging","volume":"50","author":"Hong","year":"2024","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"10.1016\/j.berh.2026.102116_bib30","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1093\/rheumatology\/keae698","article-title":"Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"64","author":"Ross","year":"2025","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2026.102116_bib31","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/rheumatology\/keae561","article-title":"Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL","volume":"64","author":"Spierings","year":"2025","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/rheumatology\/keac487","article-title":"Standardised nailfold capillaroscopy in children with rheumatic diseases: a worldwide study","volume":"62","author":"Melsens","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102116_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101978","article-title":"Capillaroscopy in the daily clinic of the pediatric rheumatologist","author":"Schonenberg-Meinema","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"Supplement 1","key":"10.1016\/j.berh.2026.102116_bib34","article-title":"Nailfold capillary changes correlates with more severe organ involvement in juvenile systemic scleroderma. Results of the juvenile scleroderma inception cohort","volume":"83","author":"Foeldvari","year":"2024","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib35","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/rheumatology\/keaa514","article-title":"Laser speckle contrast analysis predicts major vascular complications and mortality of patients with systemic sclerosis","volume":"60","author":"Gigante","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.21175","article-title":"Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis","volume":"53","author":"Paap","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","article-title":"Six-minute walk test in children and adolescents","volume":"150","author":"Geiger","year":"2007","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.berh.2026.102116_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2007.123653","article-title":"The 6-minute walk test: normal values for children of 4-11 years of age","volume":"93","author":"Lammers","year":"2008","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.berh.2026.102116_bib39","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3899\/jrheum.2022-0993","article-title":"How is pulmonary function assessed in patients with juvenile systemic sclerosis? Do we have a good clinical standard?","volume":"50","author":"Foeldvari","year":"2023","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00016-2016","article-title":"ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00010-2017","article-title":"Official ERS technical standards: Global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians","volume":"50","author":"Stanojevic","year":"2017","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.berh.2026.102116_bib42","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jcf.2013.11.006","article-title":"The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry","volume":"13","author":"Stanojevic","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2026.102116_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152672","article-title":"Imaging findings of scleroderma-associated myopathy: a systematic literature review","volume":"72","author":"Ingrid","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/acr.24499","article-title":"Underdetection of interstitial lung disease in juvenile systemic sclerosis","volume":"74","author":"Foeldvari","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.berh.2026.102116_bib47","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1093\/rheumatology\/keae394","article-title":"The 2024 British society for rheumatology guideline for management of systemic sclerosis","volume":"63","author":"Denton","year":"2024","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2026.102116_bib48","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/acr.25171","article-title":"Proposed response parameters for twelve-month drug trial in juvenile systemic sclerosis: results of the Hamburg international consensus meetings","volume":"75","author":"Foeldvari","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"1\u201313","key":"10.1016\/j.berh.2026.102116_bib49","article-title":"Characteristics of the first 80 patients at timepoint of first assessment included in the juvenile systemic sclerosis inception cohort","volume":"4","author":"Foeldvari","year":"2018","journal-title":"J Scleroderma Related Dis"},{"issue":"13","key":"10.1016\/j.berh.2026.102116_bib50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJMoa2502098","article-title":"Medical imaging and pediatric and adolescent hematologic cancer risk","volume":"393","author":"Smith-Bindman","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.berh.2026.102116_bib51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/acr.24957","article-title":"Lung ultrasound in children with systemic juvenile idiopathic arthritis-associated interstitial lung disease","volume":"75","author":"Vega-Fernandez","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2026.102116_bib52","doi-asserted-by":"crossref","DOI":"10.1590\/0100-3984.2025.0021","article-title":"Radiomics in PET\/CT and HRCT for systemic sclerosis-associated interstitial lung disease: breakthroughs and future directions","volume":"58","author":"Bastos","year":"2025","journal-title":"Radiol Bras"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101668","article-title":"Cardiac involvement in systemic sclerosis: getting to the heart of the matter","volume":"35","author":"Bruni","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","article-title":"Factors affecting survival in juvenile systemic sclerosis","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.semarthrit.2019.06.013","article-title":"T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients","volume":"50","author":"Poindron","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib56","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/rheumatology\/keac504","article-title":"Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis","volume":"62","author":"Panopoulos","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102891","article-title":"Heart transplantation in juvenile-onset systemic sclerosis with primary cardiac involvement: report of two cases and comprehensive literature review","volume":"50","author":"Bacich","year":"2025","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s42358-025-00451-w","article-title":"Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases","volume":"65","author":"Black","year":"2025","journal-title":"Adv Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102116_bib59","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.acra.2024.12.035","article-title":"The role of cardiac magnetic resonance imaging parameters in prognostication of systemic sclerosis in patients with cardiac involvement: a systematic review of the literature","volume":"32","author":"Chalian","year":"2025","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/rir-2024-0011","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: heart involvement in high-resolution","volume":"5","author":"Fairley","year":"2024","journal-title":"Rheumatol Immunol Res"},{"key":"10.1016\/j.berh.2026.102116_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251321691","article-title":"International expert agreement on world scleroderma foundation\/heart failure association consensus-based definition and guidance on screening, diagnosis, and follow-up assessment of systemic sclerosis-associated primary heart involvement","author":"Dubas","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"10.1016\/j.berh.2026.102116_bib62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","article-title":"Updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT","volume":"38","author":"Hansmann","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/acr.25235","article-title":"Prevalence and characteristics of patients with systemic sclerosis fulfilling the 2019 EULAR\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"76","author":"Bass","year":"2024","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2026.102116_bib64","article-title":"Gastrointestinal impact and tool performance in juvenile systemic sclerosis using the UCLA GIT 2.0 assessment","author":"Stefancic","year":"2025","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5455\/medarh.2025.79.305-309","article-title":"The clinical and endoscopic findings in digestive tract in progressive systemic sclerosis","volume":"79","author":"Bajraktari","year":"2025","journal-title":"Med Arch"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.rdc.2023.01.006","article-title":"Gastrointestinal tract considerations part I: how should a rheumatologist best manage common upper gastrointestinal tract complaints in systemic sclerosis?","volume":"49","author":"Quinlivan","year":"2023","journal-title":"Rheum Dis Clin N Am"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.berh.2026.102116_bib68","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8","volume":"42","author":"Lovell","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4 Suppl 23","key":"10.1016\/j.berh.2026.102116_bib69","first-page":"S1","article-title":"Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology","volume":"19","author":"Ruperto","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102116_bib70","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib71","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14397595.2020.1816612","article-title":"Effects of sense and functionality changes in the hands on activity and participation in patients with juvenile scleroderma","volume":"31","author":"Dag","year":"2021","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102116_bib72","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/acr.23547","article-title":"Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis: results from the childhood arthritis and rheumatology research alliance legacy registry","volume":"70","author":"Stevens","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2026.102116_bib73","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/art.42939","article-title":"Development and initial validation of the novel scleroderma clinical trials consortium activity index","volume":"76","author":"Ross","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2026.102116_bib75","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2026.102116_bib76","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/annrheumdis-2019-215787","article-title":"Revised European scleroderma trials and research group activity index is the best predictor of short-term severity accrual","volume":"78","author":"Fasano","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2026.102116_bib77","article-title":"Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis","volume":"I-9","author":"Klotsche","year":"2023","journal-title":"J Scleroderma Related Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12969-025-01110-6","article-title":"Application of the scleroderma clinical trials consortium damage index in patients with juvenile systemic sclerosis","volume":"23","author":"Zhang","year":"2025","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib79","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01512-2022","article-title":"Nintedanib in children and adolescents with fibrosing interstitial lung diseases","volume":"61","author":"Deterding","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2026.102116_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251342697","article-title":"A systematic literature review of Janus kinase inhibitors for the treatment of systemic sclerosis","author":"Sener","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2026.102116_bib82","first-page":"CD011819","article-title":"Stem cell transplantation for systemic sclerosis","volume":"7","author":"Bruera","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.berh.2026.102116_bib83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/1744666X.2025.2474216","article-title":"Guidance for stem cell therapy for juvenile systemic sclerosis patients","volume":"21","author":"Foeldvari","year":"2025","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2026.102116_bib84","article-title":"What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey","author":"Foeldvari","year":"2024","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.berh.2026.102116_bib85","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2665-9913(24)00282-0","article-title":"CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series","volume":"7","author":"Auth","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2026.102116_bib86","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1093\/rheumatology\/keaf141","article-title":"Using a smartphone app to monitor Raynaud's attacks and quantify skin colour changes-towards objective outcome measures for Raynaud's","volume":"64","author":"Dinsdale","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102116_bib87","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/acr2.11237","article-title":"Transition readiness in adolescents with juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus","volume":"3","author":"McColl","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102116_bib88","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1007\/s00296-024-05724-z","article-title":"Ovarian reserve alteration in premenopausal women with systemic sclerosis","volume":"44","author":"Pecher","year":"2024","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.berh.2026.102116_bib89","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/rheumatology\/kead497","article-title":"Reproductive health in female patients with systemic sclerosis: a cross-sectional study","volume":"63","author":"Dai","year":"2024","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2026.102116_bib90","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/rheumatology\/keac457","article-title":"Sexual dysfunction in women with systemic autoimmune rheumatic disorders: a systematic review and meta-analysis","volume":"62","author":"Minopoulou","year":"2023","journal-title":"Rheumatology"},{"issue":"16","key":"10.1016\/j.berh.2026.102116_bib91","article-title":"The impact of systemic sclerosis on sexual health: an Italian survey","volume":"11","author":"Ruffolo","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib92","doi-asserted-by":"crossref","DOI":"10.1186\/ar3748","article-title":"Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR scleroderma trial and research group","volume":"14","author":"Foocharoen","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.berh.2026.102116_bib93","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.2008.096909","article-title":"Erectile dysfunction in systemic sclerosis","volume":"68","author":"Walker","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102116_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/23971983221101311","article-title":"Effect of pregnancy on scleroderma progression","volume":"8","author":"Deshauer","year":"2023","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422600001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422600001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:48:12Z","timestamp":1781509692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169422600001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S152169422600001X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102116","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102116"}}